New injection aims to starve prostate cancer
Disease control
Not yet recruiting
This study is testing a new injection called Teverelix DP for men with advanced prostate cancer that has spread or cannot be cured. The drug works by quickly lowering testosterone, a hormone that fuels prostate cancer growth. Researchers will give 40 men a series of injections ov…
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC